Related content

μ-Heavy Chain Disease Associated with Systemic Amyloidosis

By Kinoshita Koji   Yamagata Toshiaki   Nozaki Yuji   Sugiyama Masafumi   Ikoma Shinya   Funauchi Masanori   Kanamaru Akihisa  

Hematology, Vol. 9, Iss. 2, 2004-04 ,pp. : 135-137

Maney Publishing

Access to resources Recommend Favorite

Localized Castleman’s disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal

By Androulaki A.   Giaslakiotis K.   Giakoumi X.   Aessopos A.   Lazaris A.  

Annals of Hematology, Vol. 86, Iss. 1, 2007-01 ,pp. : 55-57

Springer Publishing Company

Access to resources Recommend Favorite

Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis

By Caccialanza Riccardo   Palladini Giovanni   Klersy Catherine   Cereda Emanuele   Bonardi Chiara   Cameletti Barbara   Montagna Elisabetta   Russo Paola   Foli Andrea   Milani Paolo   Lavatelli Francesca   Merlini Giampaolo  

Annals of Hematology, Vol. 91, Iss. 3, 2012-03 ,pp. : 399-406

Springer Publishing Company

Access to resources Recommend Favorite

Hemophagocytic syndrome in a pregnant patient with systemic lupus erythematosus, complicated with preeclampsia and cerebral hemorrhage

By Pérard Laurent   Costedoat-Chalumeau Nathalie   Limal Nicolas   Hot Arnaud   Cohen Judith   Vauthier-Brouzes Danièle   Nieszkowska Ania   Belmatoug Nadia   Piette Jean-Charles  

Annals of Hematology, Vol. 86, Iss. 7, 2007-07 ,pp. : 541-544

Springer Publishing Company

Access to resources Recommend Favorite

Cerebrovascular Amyloidosis and Dementia

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 3, Iss. 4, 2003-12 ,pp. : 317-327

Bentham Science Publishers

Access to resources Recommend Favorite